Zydus Lifesciences Limited
Zydus Lifesciences Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: ZYDUSLIFE and BSE: 532321 (ISIN INE010B01027).
It has a market capitalisation of ₹1.12 lakh crore, a last close of ₹1,114 on 2026-10-19, a one-year return of 12.8%.
Valuation: a price-to-earnings ratio of 24.83x, a price-to-book ratio of 4.13x, a dividend yield of 0.1%.
Profitability: return on equity of 19.7%, return on capital employed of 21.8%, an operating margin of 29.1%.
Growth: sales growth of 16.3% a year over three years, net profit growth of 37.0% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.43x, promoter holding of 75.0%.
| Metric | Value |
|---|---|
| Market capitalisation | 1.12 L Cr |
| Last close | ₹1,114 |
| P/E (TTM) | 24.83x |
| P/B | 4.13x |
| Dividend yield | 0.1% |
| ROE (FY) | 19.7% |
| ROCE (FY) | 21.8% |
| Operating margin (TTM) | 29.1% |
| Sales growth, 3-year CAGR | 16.3% |
| Profit growth, 3-year CAGR | 37.0% |
| Debt / equity | 0.43x |
| Promoter holding | 75.0% |
| 1-year return | 12.8% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means